ATOS

Latest SEC Filings & News for ATOS

2 most recent filings and news items mentioning ATOS. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/ATOS/news?limit=20"

Pull ATOS filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

EarningsAug 7, 2026Neutral

Atossa reports Q2 2026 financial results, scientific advances for (Z)-endoxifen

Atossa Therapeutics reported second quarter 2026 financial results, highlighting clinical profile developments and rare pediatric disease designations, with updates on oncology science presented at ASCO and AACR conferences.

View filing at SEC.gov →

OfferingJun 11, 2026Neutral

Atossa Therapeutics issues Series A/B common stock purchase warrants dated June 12, 2026

Atossa Therapeutics has issued common stock purchase warrants exercisable beginning December 12, 2026, with terms defined in a June 10, 2026 Securities Purchase Agreement. The warrants allow holders to purchase company common stock at specified exercise prices through termination

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.